We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
See and hear How we Tell Our Corporate Story
ABOUT QBIO by OUR CEO
QUARTERLY & ANNUAL REPORTS
PRESS AND NEWS
Veteran Novartis and WuXii Global Head of Pharmaceutical Development Joins Company BoardNEW YORK, February 13, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to welcome Dr. Rick Panicucci as an independent member on...
Q Biomed Inc. Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma
Potential Companion Diagnostic Compliments MAN-01 Pipeline Glaucoma DrugNEW YORK, February 8, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), is pleased to announce an exclusive option agreement with Washington University in St. Louis. Under the agreement granting...
Company Expects Commercialization and Revenue from its Non-Opioid Pain Palliation Drug in Q2 2018 and Initiation of Multiple Pivotal Clinical Programs in 2018NEW YORK, February 1, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology...
SEE OUR REPORTS AND FILINGS
Copyright © 2017 Q BioMed, Inc. All Rights Reserved
501 Madison Ave, 14th Floor
New York, NY 10022 USA
P: +1 888 357 2435